^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DNADX®

    Company:
    Reveal Genomics
    Type:
    Research Use Only
    Related tests:
    Details
    Evidence

    News

    30d
    STUDY LINKS REVEAL GENOMICS ASSAYS HER2DX AND DNADX TO RESPONSE TO TRASTUZUMAB DERUXTECAN IN METASTATIC BREAST CANCER (Reveal Genomics Press Release)
    "REVEAL GENOMICS...has announced the publication of new research in npj Precision Oncology demonstrating that its HER2DX and DNADX assays are associated with clinical outcomes to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer."
    Clinical
    |
    DNADX® • HER2DX